WO2023037264 - CONTRACEPTIVE REGIMEN INCLUDING REDUCED LEVEL OF ESTROGEN
National phase entry:
Publication Number
WO/2023/037264
Publication Date
16.03.2023
International Application No.
PCT/IB2022/058420
International Filing Date
07.09.2022
Title **
[English]
CONTRACEPTIVE REGIMEN INCLUDING REDUCED LEVEL OF ESTROGEN
[French]
RÉGIME CONTRACEPTIF COMPRENANT UN NIVEAU RÉDUIT D'OESTROGÈNE
Applicants **
MILLICENT PHARMA LIMITED
Inventors
BOISSONNEAULT, Roger M.
LOUGHLIN, Ryan
Priority Data
63/241,178
07.09.2021
US
17/483,199
23.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2631 | |
| EPO | Filing, Examination, Granting | 18161 | |
| Japan | Filing, Examination, Granting | 2839 | |
| South Korea | Filing, Examination, Granting | 3554 | |
| USA | Filing, Examination, Granting | 10340 |
Total:
37,525
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A contraceptive regimen that provides for a reduced level of estrogen. The contraceptive regimen can be used for the treatment of symptoms associated with endometriosis or fibroids.[French]
L'invention concerne un régime contraceptif qui permet une réduction du niveau d'oestrogène. Le régime contraceptif peut être utilisé afin de traiter des symptômes associés à l'endométriose ou à des fibromes.